Address: | 301 E & F, Thomas Cherry Building, Bundoora VIC 3086, Australia |
---|---|
Postal code: | 3086 |
Phone: | (03) 9479 2584 |
Website: | https://akaalpharma.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Akaal Pharma Pty Ltd., use the form below and your opinion, advice or comment will appear in this space.
Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma's First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals).
About Akaal Pharma: Akaal Pharma Pty Ltd (Akaal Pharma) is a clinical-stage drug discovery and development company Dale Dhanoa, Ph.D., CEO Akaal Pharma Pvt Ltd Phone: +1 858 925-4555 (San Diego, CA, USA), +61 3 9479 2584 (Melbourne, Australia) E-mail: info@akaalpharma.com.
12-29-2011. Patent applications by Akaal Pharma Pty Ltd.
Akaal Pharma Pty Ltd, (Akaal Pharma), a clinical-stage biopharmaceutical company today announced the approval to initiate a randomized, double-blind +61 3 9479 2584 (Australia) info@akaalpharma.com.
Akaal pharma pty ltd is a leading drug discovery company of Australia. Its drugs are used for treatment of autoimmune diseases and inflammation. The address of Akaal pharma pty ltd is 51 Yarcombe Crescent, Craigieburn Victoria 3064. data-ad-slot="7829909793">.
Viimeisimmät twiitit käyttäjältä Akaal Pharma (@Akaal_Pharma). Akaal Pharma is a clinical-stage drug discovery and development biopharmaceutical Akaal Pharma Pty Ltd. Thomas Cherry Building, #301 E & F Chemistry Department, La Trobe University, Bundoora, VIC - 3086, Australia.
Note: Akaal Pharma Pty Ltd may have other listings under different names/spellings. The compositions find use in the treatment of disease, particularly inflammation and immune mediated disorders.. ... Akaal Pharma Pty Ltd.
Akaal Pharma Pty Ltd is one of thousands of patent owners that we feature on IP in Australia which contains details of the over 1 million patents registered in Australia. We provide this information to help Australians with their research in the intellectual property space but to also help inventors (first time or...
Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma's First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals).
Bal Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 2018 2. Consolidated Bal Pharma Limited has informed the Exchange regarding a press release dated March 06, 2018, titled " AKAAL PHARMA PTY LTD AND BAL PHARMA LTD TO DEVEL...